GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of the SURPASS question that gets asked weekly, answered properly — 65 comments in the full submission. View in context.
2.2k
c/trialwatch·submitted 5 months ago by u/plateau_patrol

the SURPASS question that gets asked weekly, answered properly

Readoutbranch of 7 comments

Posting this because I searched for it and got nothing useful. Setup: 1.0mg, week 90, injection-site soreness present but not ruining anything. I changed exactly one variable — TRIUMPH — and tracked it for 8 weeks. Result: a difference, but a small one, and well inside what I would call noise if someone else posted…

Read the full submission and all 65 comments →

This branch

7 comments, started 5 months ago
u/receipts_or_nothingvetting325 points·5 months ago

Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.

replysharereportpermalink
[deleted]121 points·5 months ago

[deleted]

replysharereportpermalink
u/anders_karlsen461 points·5 months ago

What was the dropout rate?

replysharereportpermalink
u/plateau_patrolOP338 points·5 months ago

dropout handling matters, especially on GI-heavy populations

replysharereportpermalink
u/slow_logbook_notes30218 points·5 months ago

press release SURMOUNT posts must be flaired until a publication exists

replysharereportpermalink
u/cold_chromatogram3165 points·5 months ago

Not to be pedantic but FLOW and endpoint are being used interchangeably and they are not interchangeable in real life.

replysharereportpermalink
u/joaquin_stanescu210 points·5 months ago

dropout handling matters, especially on GI-heavy populations

Yes, exactly this, and it is the bit that took me 10 weeks to accept.

replysharereportpermalink

← back to the whole thread

About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/trialwatch
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/trialwatch_theou/forest_plot_fionau/hazard_ratio_halu/renal_outcomes_r
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →